More to explore:

Bones

There’s more to see...
Sign up to discover and save different things to try in 2015.
Visit Site
Richard Meyer
Richard Meyer • 3 years ago

Medtronic Inc said it agreed to pay $85 million to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse, a genetically engineered bone graft used in spinal surgery.

About this Pin